These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20200423)

  • 1. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.
    Graves KD; Wenzel L; Schwartz MD; Luta G; Wileyto P; Narod S; Peshkin BN; Marcus A; Cella D; Emsbo SP; Barnes D; Halbert CH
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):648-54. PubMed ID: 20200423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
    Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
    Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
    J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
    Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
    Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1/2 genetic testing uptake and psychosocial outcomes in men.
    Graves KD; Gatammah R; Peshkin BN; Krieger A; Gell C; Valdimarsdottir HB; Schwartz MD
    Fam Cancer; 2011 Jun; 10(2):213-23. PubMed ID: 21365268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
    J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.
    Hooker GW; Leventhal KG; DeMarco T; Peshkin BN; Finch C; Wahl E; Joines JR; Brown K; Valdimarsdottir H; Schwartz MD
    Med Decis Making; 2011; 31(3):412-21. PubMed ID: 20876346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.
    Miller SM; Roussi P; Daly MB; Buzaglo JS; Sherman K; Godwin AK; Balshem A; Atchison ME
    Health Educ Behav; 2005 Oct; 32(5):654-67. PubMed ID: 16148211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
    Beran TM; Stanton AL; Kwan L; Seldon J; Bower JE; Vodermaier A; Ganz PA
    Ann Behav Med; 2008 Oct; 36(2):107-16. PubMed ID: 18787910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes.
    Shiloh S; Dagan E; Friedman I; Blank N; Friedman E
    Psychooncology; 2013 Feb; 22(2):417-25. PubMed ID: 22135240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of a telephone-based peer-support program for women carrying a BRCA1 or BRCA2 mutation: impact on psychological distress.
    White VM; Young MA; Farrelly A; Meiser B; Jefford M; Williamson E; Ieropoli S; Duffy J; Winship I
    J Clin Oncol; 2014 Dec; 32(36):4073-80. PubMed ID: 25403211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
    Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
    Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
    Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
    J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
    Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
    Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations.
    Esplen MJ; Hunter J; Leszcz M; Warner E; Narod S; Metcalfe K; Glendon G; Butler K; Liede A; Young MA; Kieffer S; DiProspero L; Irwin E; Wong J
    Cancer; 2004 Nov; 101(10):2327-40. PubMed ID: 15478194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
    Patenaude AF; Tung N; Ryan PD; Ellisen LW; Hewitt L; Schneider KA; Tercyak KP; Aldridge J; Garber JE
    Psychooncology; 2013 Sep; 22(9):2024-31. PubMed ID: 23417902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
    Halbert CH; Schwartz MD; Wenzel L; Narod S; Peshkin BN; Cella D; Lerman C
    J Behav Med; 2004 Aug; 27(4):373-92. PubMed ID: 15559734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.